Corient Private Wealth
EFTR

Corient Private Wealth’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Corient Private Wealth’s Portfolio EFTR Stock Details EFTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,018
Closed -$118K – 2040
2022
Q4 		$118K Buy
+11,018
New +$118K ﹤0.01% 1548